By using the cut-off derived from the ROC analysis, the predictive ability of S100A9, MUC5AC, TGF-β1, angiopoietin-2, and CA19-9 on CCA diagnosis was investigated. This evidence concerns the gene S100A9 and cholangiocarcinoma.